SAN DIEGO, July 16, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, announces that a class action lawsuit has commenced on behalf of investors of Fortrea Holdings Inc. (NASDAQ: FTRE). The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges: (i) Fortrea overestimated the amount of revenue the Pre-Spin Projects were likely to co ...

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Centene Corporation (NYSE: CNC)?Did you purchase your shares between December 12, 2024 and June 30, 2025, inclusive?Did you lose money ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Centene Corporation for alleged misrepresentations regarding the company's enrollment and morbidity rates during a specified period [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased or acquired Centene's securities between December 12, 2024, and June 30, 2025 [1]. - Defendants are accused of making misrepresentations about the state of Centene's enrollment and morbidity rates [2]. Group 2: Lead Plaintiff Information - Interested parties wishing to serve as lead plaintiff must file papers by September 8, 2025 [3]. - Serving as lead plaintiff is not a requirement for sharing in any potential recovery, and shareholders can remain absent class members if they choose not to take action [3]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [4].

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into DexCom, Inc. for potential breaches of fiduciary duties and violations of federal securities laws due to misleading public statements made by certain insiders regarding the company's expansion strategy and market share [1][2]. Summary by Relevant Sections Investigation Details - The investigation focuses on actions taken by DexCom insiders between April 28, 2023, and June 5, 2024, which led to the issuance of false and misleading statements about the company's growth and market position [2]. - DexCom began making corrective disclosures starting April 25, 2024, revealing that its growth and business prospects were significantly lower than previously claimed [2]. - By the final corrective disclosure on July 25, 2024, DexCom's share price had decreased by over 40.6% [2]. Shareholder Rights - Current stockholders who held DexCom stock before April 28, 2023, are encouraged to contact Johnson Fistel to discuss their legal rights regarding the investigation [3].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Open Lending Corporation, following allegations of misrepresentation and failure to disclose critical financial information [1][2]. Group 1: Allegations of Misrepresentation - Insiders at Open Lending allegedly caused the company to misrepresent or fail to disclose key aspects of its financial health, including risk-based pricing models and profit share revenue [2]. - The company reportedly failed to disclose that its 2021 and 2022 vintage loans had significantly decreased in value compared to their outstanding loan balances [2]. - There are claims regarding the underperformance of the company's 2023 and 2024 vintage loans, which contributed to misleading positive statements about the company's business and prospects [2]. Group 2: Legal Action and Shareholder Rights - Kuehn Law is reaching out to shareholders who purchased LPRO shares prior to February 24, 2022, to inform them of their potential rights and the limited time available to enforce those rights [3]. - The firm emphasizes the importance of shareholder participation in maintaining the integrity of financial markets [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Hims & Hers Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The Class Period for the lawsuit is from April 29, 2025, to June 23, 2025, and the lead plaintiff deadline is August 25, 2025 [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5] Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [3] - In 2019, Rosen Law Firm secured over $438 million for investors, showcasing its effectiveness in representing clients [3] Group 3: Case Allegations - The lawsuit alleges that Hims made false and misleading statements regarding its partnership with Novo Nordisk A/S, particularly about the availability of the weight-loss drug Wegovy [4] - Specific claims include that Hims misrepresented the nature of its collaboration with Novo and the offerings of compounded semaglutide products [4] - The lawsuit asserts that when the true details were revealed, investors suffered damages due to the misleading information [4]

Core Viewpoint - Johnson Fistel, PLLP is investigating KinderCare Learning Companies, Inc. (NYSE: KLC) for potential violations of securities laws related to misrepresentation or failure to disclose material information to investors [1] Group 1: Investigation Details - The investigation focuses on whether KLC or its executives misrepresented or failed to timely disclose important information to investors [1] - Investors who purchased KLC securities and suffered losses are encouraged to join the investigation [2] Group 2: Whistleblower Information - Individuals with nonpublic information about KLC are advised to consider assisting the investigation or utilizing the SEC Whistleblower program, which may offer rewards up to 30% of successful recoveries [3] Group 3: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights, with offices across multiple states [4] - The firm has been ranked in the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services in 2024, recovering approximately $90.725 million for clients [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Bitfarms Ltd. securities during the specified Class Period of the upcoming lead plaintiff deadline on July 8, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Bitfarms securities between March 21, 2023, and December 9, 2024, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must act by the July 8, 2025, deadline to serve as lead plaintiff [2]. - The lawsuit alleges that Bitfarms made false and misleading statements regarding its financial reporting and internal controls, which led to inaccurate financial statements that may need to be restated [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3].

Core Viewpoint - A class action securities lawsuit has been filed against Bitfarms Ltd. alleging securities fraud affecting investors between March 21, 2023, and December 9, 2024 [1][2]. Group 1: Allegations and Financial Misstatements - The lawsuit claims that Bitfarms had inadequate internal controls over financial reporting [2]. - It is alleged that the company misclassified proceeds from the sale of digital assets, categorizing them as cash flow from operating activities instead of investing activities [2]. - The complaint also states that Bitfarms overstated its ability to remediate material weaknesses in its internal controls related to the classification of the 2021 Warrants [2]. - These errors purportedly led to misstatements in several previously issued financial statements, which may require restatement [2]. - Consequently, the public statements made by the company were deemed materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until July 8, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and has been recognized as a top securities litigation firm in the United States for seven consecutive years [4].

Industry Recognition - Forbes 发布了伊利诺伊州最佳律师名单 [1]